✦ LIBER ✦

Gene therapy in lung cancer

✍ Scribed by Stephen G. Swisher; Jack A. Roth

Publisher: Current Science Inc.
Year: 2000
Tongue: English
Weight: 282 KB
Volume: 2
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-000-0012-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53tumour-suppressor gene in non-small-c

p53tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy

✍ K. Junker; T. Wiethege; K.-M. Müller; M. Thomas 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Monocyte chemoattractant protein-1 gene

Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice

✍ Hiroshi Nokihara; Yasuhiko Nishioka; Seiji Yano; Naofumi Mukaida; Kouji Matsushi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 166 KB 👁 2 views

Distant metastases and multidrug resistance are critical problems in the therapy of human small cell lung cancer (SCLC). In this study, we investigated whether transduction of the monocyte chemoattractant protein-1 (MCP-1) gene into multidrug-resistant (MDR) human lung cancer cells affected the form

Gene therapy for lung cancer

✍ Eric M. Toloza; Michael A. Morse; H. Kim Lyerly 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract Lung cancer patients suffer a 15% overall survival despite advances in chemotherapy, radiation therapy, and surgery. This unacceptably low survival rate is due to the usual finding of advanced disease at diagnosis. However, multimodality strategies using conventional therapies only mini

Denaturing capillary electrophoresis for

Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy

✍ Lucie Benesova; Milos Pesek; Barbora Belsanova; Patrik Sekerka; Marek Minarik 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The presence of activating mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene has been attributed to a positive response to biological therapy of lung cancer by small‐molecular tyrosine kinase inhibitors, gefitinib and erlotinib. Among the two most

A novel high-resolution chipCE assay for

A novel high-resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA

✍ Marek Minarik; Marcus Gassman; Barbora Belsanova; Milos Pesek; Jan Schouten; Ric 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

There is a growing interest in evaluating molecular markers as predictors of response to new generation of targeted cancer therapies. One of such areas is biological therapy targeting epidermal growth factor receptor gene (EGFR) in lung cancer. The testing of tumor tissue is focused on specific EGFR

Combined therapy with anti-p-glycoprotei

Combined therapy with anti-p-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in nk cell-depleted scid mice

✍ Seiji Yano; Masaki Hanibuchi; Yasuhiko Nishioka; Hiroshi Nokihara; Naoki Nishimu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB 👁 2 views